Medication leaflets

Active substance

Results for the substance nonacog beta pegol

4 results

About this active substance

Nonacog beta pegol is a long-acting recombinant factor IX used in the treatment and prevention of bleeding episodes in patients with hemophilia B. It provides extended protection against bleeding due to its molecular modification.

The medication is administered intravenously, as directed by a doctor, usually at longer intervals than conventional factor IX products. It is important for patients to follow the treatment regimen and undergo regular tests to monitor factor IX levels.

Patients should be aware of potential side effects, such as injection site reactions, headaches, or fatigue. It is important to inform the doctor of any unusual symptoms.

Common side effects include injection site reactions, headaches, and fatigue. In rare cases, severe reactions such as allergic reactions or the development of factor IX inhibitors may occur. Patients should be informed of these risks before use.